Match Document Document Title
DE102005010328A1 A process for reducing the concentration of sulfur and / or a sulfur containing compound of a sugar, a sugar alcohol and / or a sugar acid  
process to the concentration of sulfur and / or a sulfur containing compound of a sugar, a sugar alcohol and / or a sugar acid by one sugar, sugar alcohol and / or the sugar acid in the liquid...
DE102005006388A1 Replication-deficient RNA viruses as vaccines  
The This invention relates to a genome-replication-deficient and transcription-competent negative-strand RNA virus, which for Expression of transgenes and in particular for the area of ​​vaccine...
DE10154254B4 sealing arrangement  
sealing arrangement at a connection between a wheel hub (11) in a wheel bearing (16) is held and on the adjacent said bearing inner ring (18) of the wheel bearing (16) is a flanged sleeve (26)...
DE102005005199A1 Use of alkyl glucoside for obtaining or improving the microbiological stability of cosmetic or dermatological preparations, which contain preservatives and for protecting organic products from the attack of the mycobiont  
Use of alkyl glucoside (I) for obtaining or improving the microbiological stability of cosmetic or dermatological preparation, which contains preservatives. Use of alkyl glucoside of formula (I)...
DE102005005054A1 Hydrophilic bioquinone compound, processes for their preparation and their use  
It is a compound having a bioquinone bound to a sugar, a process for their preparation, a composition comprising said compound and the use of this compound or composition for the manufacture...
DE102005004228A1 Solubilizate of a water soluble organic acid and a process for its preparation  
to Improving the effectiveness of citric acid, especially in oily and greasy media, a solubilized preparation consisting of an aqueous solution of citric acid and / or a citric acid and an...
DE10010280B4 A method for the detection of cytosine methylation in DNA samples  
process for the detection of 5-methylcytosine in genomic DNA samples, characterized in that one performs the steps of: (A) a genomic DNA from a DNA sample with a reagent Chemically speaking, with...
DE202005010007U1 Device for separating insolubles from biological fluid samples, e.g. nucleic acids from cellular lysates, comprises a separating column with a filter element acting like a deep-bed filter in the top of the column  
A device (1, 2, 3) for separating insoluble ingredients from a biological sample fluid in the form of a lysate, comprising a columnar outer vessel (4) with a filler opening (5) at the top...
DE19632862B4 Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines  
immunological active protein of Borrelia burgdorferi, the of in another present from Borrelia burgdorferi proteins derived free form, characterized in that it the sequence of the protein 1829-22A...
DE102005005528A1 Using nucleic acid to prepare injectable agent for transportation to retinal ganglion cells, useful in treatment of glaucoma and diabetic complications of the eye, acts especially by RNA intereference  
Using a nucleic acid (I) for preparing an injectable agent (A) that is transported, in a targeted manner, into retinal ganglion cells (RGC), is new. Independent claims are also included for: (1)...
DE102005003638A1 Nucleic acid hybridization techniques  
It If the improved in situ hybridization with nucleic acid and the hybridization method shortened will.According to the invention, the Nucleic acid hybridization techniques under the influence of...
DE102005001191A1 Device and method for the fractionation of the mono- and / or oligosaccharide structures  
The This invention relates to an apparatus for affinity chromatography reversible binding of mono- and / or oligosaccharide structures. Furthermore, the present invention relates to a process for...
DE19713768B4 Production of betulinic  
manufacturing of betulinic acerifolia from the dry pulverized bark of Platanus, by Extraction with dichloromethane, chloroform or diethyl ether as the polar medium Solvents, Concentration of the...
DE102004063099B4 A process for preparing Thiophenglycosidderivaten  
process for the preparation of compounds of general formula (I): which mean YH, (C1-C10) Alkyl; R1 (C1-C8th) -alkyl, Where one, several, or all hydrogen (s) may be replaced by fluorine; (C5-C10)...
DE102004063099A1 A process for preparing Thiophenglycosidderivaten  
It is a process for preparing Thiophenglycosidderivaten of the general formula (I) described, in which: Y is hydrogen or alkyl, R1 is alkyl, wherein hydrogens by fluorine may be replaced or Aryl,...
DE112004000265T5 Novel photolabile protecting groups for improved methods for the preparation of oligonucleotide arrays  
connection having the general formula: where R1 COOY , where Y is selected from the group consisting of an optionally substituted Alkyl group having up to 10 carbon atoms under the condition...
DE102004063339A1 Probe for detecting nucleic acids  
The Invention relates to a probe for detecting nucleic acids, method for the preparation of the probe, methods of making a detection reactions and test kits that contain those reagents necessary...
DE102004061145A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE102004058449A1 tetrahydropyran  
New Compounds of the formula I, whereinT, E, R, R ', R' ', R1, R2 and R2 ' the meanings given in claim 1 have,useful as antidiabetics.
DE20023815U1 Azithromycin-containing compositions  
Pharmaceutical A composition comprising azithromycin in the form of a stable Monohydrate and at least one pharmaceutical carrier or Filler, wherein the azithromycin monohydrate is prepared by a...
DE102004058811A1 A process for the production of sugar alcohols  
It is a process for the preparation of polyalcohols, in particular Sugar alcohols from the group sorbite and mannitol and if necessary further polyols, proposed by a mono-, di-, oligo- or...
DE10145553B4 Nucleic acid for a cloning  
process for preparing a nucleic acid in a cloning vector or suitable for incorporation into a cloning vector, the method comprising the steps of: (A) providing a nucleic acid, at least one of...
DE102004056980A1 A method for site-specific synthesis of biopolymers on solid supports  
The Invention relates to methods for site-specific synthesis of biopolymers such as nucleic acids or peptides, and their respective derivatives on solid supports, wherein the local Discrimination...
DE102004034849B4 A process for preparing oat husks for xylan production  
According to the invention is a Oat husks for xylan production having the step, oat hulls by roughen a roll mill at its surface, wherein the coating layer partially destroyed the oat hulls , while...
DE19882655B4 A process for producing a probe for nucleic acid hybridization  
process for the manufacture of probes with or Oligodesoxyribonukleinsäuren Nucleic acid analogs a sequence detection part (SET) and a reporter group (RG), wherein the probes sufficiently...
DE19810349B4 Chitindeacetylasegen, vector containing this gene and transformants  
Polynucleotide molecule, a the Protein deacetylase for N-acetyl groups in N-acetylated Aminozuckerresten or a functional fragment it encodes, said polynucleotide molecule (A) is a polynucleotide...
DE19603629B4 A process for preparing alkyl glycoside  
process for the production of an alkyl glycoside by reaction of a saccharide and a monohydric alcohol or phenol, which process comprises comprising steps of: implementation of Reaction of the...
DE102004054603A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-Xylopyranosyl-substituted phenyl compounds (I) and tautomers and/or stereoisomers and salts are new. D-Xylopyranosyl-substituted phenyl compound of formula (I) and tautomers and/or stereoisomers...
DE19602464B4 Apparatus for multiple, simultaneous and parallel synthesis of chemical compounds and discrete follow aliquots  
device for multiple, simultaneous and parallel synthesis of chemical compounds with a holder (46) having a plurality of reaction vessels (12) an upper opening (22), said upper openings (22) the...
DE102004051804A1 Beta-L-N4-hydroxycytosine-deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases  
The Invention relates to β-L-N4-hydroxycytosine nucleosides and pharmaceutical compositions comprising them and the use of the β-L-N4-hydroxycytosine nucleosides and the pharmaceutical agent for...
DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin  
Novel recombined polypeptide which is an antibody or an antibody fragment, which binds the ED-B domain of Fibronectin, and inhibits the interaction between the ED-B domain and its receptors....
DE10328813B4 Method for investigating cytosine methylation in DNA sequences by means triplexbildender oligomers  
process for the detection of cytosine methylations in DNA, characterized in that that the to be examined with a DNA molecule into contact triplexbildenden brings that distinguishes between...
DE4414863B4 A process for producing storable sulfosuccinates and Sulfosuccinamates  
process for the preparation of storage-stable sulfosuccinates and sulfosuccinamates by reaction of fatty alcohols or fatty amines or alkylene oxide adducts thereof with maleic anhydride and...
DE10231370B4 Thiophenglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 Hydrogen, F, Cl, Br, I, OH, CF3, NO2, CN, COOH, CO (C1-C6) Alkyl, COO (C1-C6) Alkyl, CONH2, CON (C1-C6) -alkyl, CON [(C1-C6) Alkyl]2, (C1-C6) Alkyl,...
DE102004048390A1 New inhalation powders based on modified lactose mixtures as an adjuvant  
The Invention relates to a novel production method for displaying modified Lactose mixtures, these mixtures of lactose as such and composition medicaments for inhalation powder, consisting of one...
DE102004048389A1 Modifying surfaces of lactose as an excipient for use in powdered inhalants  
The Invention relates to a method for surface energy passivation of lactose, in the manufacture of inhalable powders as an excipient should be employed, as well as the use of such an optimized...
DE102004048388A1 D-pyranosyl substituted phenyls, medicaments containing these compounds, their use and processes for their preparation  
D-pyranosyl substituted Phenyls of general formula I, wherein the radicals R1 to R5, X, Z and R7a, R7b, R7c are as defined in claim 1, having an inhibitory effect on the sodium-dependent glucose...
DE102004047722B4 A method for isolating and separating carbohydrates from aqueous media and use of ionic liquids for the extraction of carbohydrates  
process for isolating carbohydrates from aqueous media, characterized in that one (A) an extraction of the aqueous medium with an organic solvent or an ionic liquid is carried out which the...
DE102004047722A1 A method for isolating and separating carbohydrates from aqueous media  
The This invention relates to a method for isolating and separating carbohydrates, particularly monosaccharides, disaccharides and / or Oligosaccharides from aqueous Media, wherein the organic...
DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells  
Isolated protein or peptide (I) comprising an amino acid sequence selected from (SEQ ID No.:1)-(SEQ ID No.:1 46), as given in the specification, is new. Independent claims are also included for:...
DE102004046116A1 Pullulanases from psychrophilic organisms  
The This invention relates to novel hydrolases, in particular pullulanases, from psychrophilic organisms and their use.
DE10347710B4 Recombinant vaccines and their use  
Fusion molecule, the Antigen, a transmembrane region and the cytoplasmic region a chain of an MHC molecule includes.
DE102004062597A1 Method to modify hyaluronate gel to produce a supramolecular gel, useful e.g. as medicine product to treat skin problems, comprises agitating aqueous hyaluronate solution for long time, exposing to UV radiation and distilling the solution  
A method for the modification of a hyaluronate gel to produce a supramolecular gel (I), which in its modified condition is able to penetrate the skin barrier and resumes it's original stable...
DE102004046583A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-xylopyranosyl-phenyl-substituted cycle compounds, their tautomers, stereoisomers, mixtures and salts are new. D-xylopyranosyl-phenyl-substituted cycle compounds of formula (I), their tautomers,...
DE102004046012A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes  
D-glucopyranosylphenyl-substituted cyclic compounds (I) are new. D-glucopyranosylphenyl-substituted cyclic compounds of formula (I) and their tautomers, stereoisomers and salts, other than...
DE102004036314A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes  
D-glucopyranosylphenyl-substituted cyclic compounds (I) are new. D-glucopyranosylphenyl-substituted cyclic compounds of formula (I) and their tautomers, stereoisomers and salts, other than...
DE102004035337A1 Variants of the group 1 allergens from Poaceae with reduced allergenicity and received T cell reactivity  
The This invention relates to the preparation and use of Variants of the group 1 allergens of the Poaceae (grasses), which the by opposite known wild-type allergens reduced IgE reactivity and...
DE10222632B4 Microsatellite markers for genetic analysis and to distinguish it from roses  
oligonucleotides microsatellite markers of Rose genome characterized by the following sequences:
DE102004045332B3 Process and assembly to elute single and twin-strand nucleic acids from a sample substrate substance in the presence of a bivalent metal ion  
A process insulates and separates single and twin-strand nucleic acids from a sample substrate substance. The twin-stranded nucleic acids are eluted with a first elution solution and the...
DE10040380B4 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties  
Use of perfluoroalkylated metal complexes (I), having a critical micelle formation concentration of less than 1 mM, a hydrodynamic micelle diameter of more than 1 nm and a proton relaxivity in...